This site is no longer being maintained. Please visit our new site at http://attcnetwork.org.

Este sitio ya no se mantiene. Por favor visite nuestro nuevo sitio en http://attcnetwork.org .

Prescription Opioid Addiction Treatment Study (POATS)

Overview
Treatment Strategies for Prescription Opioid Dependence is a package of tools and training resources for substance use disorders treatment providers. The Blending Package describes how buprenorphine works and presents the results of a National Drug Abuse Clinical Trials Network (CTN) study that compared brief and extended buprenorphine treatments. The results of the study have implications for the treatment of adults dependent on prescription opioids. The POATS Blending Team (BT) package is designed to help treatment providers incorporate study findings and recommendations into their practice.

To obtain an overview of the POATS Blending product, download the factsheet.

Blending Product Materials (download the FREE materials)

  • A clinician training program and manual
  • A PowerPoint presentation
  • A resource list
  • Fact sheets for clinicians (e.g., buprenorphine, methadone, and naltrexone)
  • Research and resources about buprenorphine treatment
  • Additional materials to help provides implement and promote buprenorphine treatment in practice

 

POATS Blending Team Members

NIDA/NDAT CTN
Roger Weiss, MD, Harvard Medical School, McLean Hospital
Hilary Smith Connery, MD, PhD, Harvard Medical School, McLean Hospital
Joshua D. Lee, MD, MSc, New York University, Langone Medical Center
Jennifer Sharpe Potter, PhD, MPH, University of Texas, Health Science Center

SAMHSA/CSAT-ATTC
Thomas E. Freese, PhD, Pacific Southwest ATTC (Co-Chair)
Beth Rutkowski, MPH, Pacific Southwest ATTC (Co-Chair)
Leslie Cohen, ATTC of New England
Traci Rieckmann, PhD, Northwest Frontier ATTC

 

ATTC Network Home      Treatment & Help      The ATTC Hub        Contact Us      Site Map      Copyright Information      Join Our Email List
Site Developed by KC Web Programmers